Pneumococcal carriage in children with COVID-19

References

• World Health Organization. Pneumococcal diseases. 2015 Nov 16. [accessed 2015 Nov 26]. https://www.who.int/biologicals/vaccines/pneumococcal/en/
   Google Scholar
• Zhu X, Ge Y, Tao Wua T, Zhao K, Chen Y, Wu B, Zhu F, Zhu B, Cui L. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005. doi:10.1016/j.virusres.2020.198005.
   PubMed Web of Science ®Google Scholar
• Shrestha S, Foxman B, Daniel M, Weinberger DM, Viboud C, Rohani P. Identifying the interaction between influenza and pneumococcal pneumonia using incidence data. Sci Transl Med. 2013;5:191ra84. doi:10.1126/scitranslmed.3005982.
   PubMed Web of Science ®Google Scholar
• Rudd JM, Ashar HK, Chow VTK, Teluguakula N. Lethal synergism between influenza and Streptococcus pneumoniae. J Infect Pulm Dis. 2016;2. doi:10.16966/2470-3176.114.
   PubMedGoogle Scholar
• Brealey JC, Sly PD, Young PR, Chappell KJ. Viral bacterial co-infection of the respiratory tract during early childhood. FEMS Microbiol Lett. 2015;362:fnv062.
   PubMed Web of Science ®Google Scholar
• Ghoneim HE, Thomas PG, McCullers JA. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol. 2013;191:1250–59. doi:10.4049/jimmunol.1300014.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Klugman KP, Group TVT. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811–13. doi:10.1038/nm1077.
   PubMed Web of Science ®Google Scholar
• Smith AM, Adler FR, Ribeiro RM, Gutenkunst RN, McAuley JL, McCullers JA, Perelson AS. Kinetics of coinfection with influenza A virus and streptococcus pneumoniae. PLoS Pathog. 2013;9:e1003238. doi:10.1371/journal.ppat.1003238.
   PubMed Web of Science ®Google Scholar
• Wang L, Fu J, Liang Z, Chen J. Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae in China: a meta-analysis. BMC Infect Dis. 2017;17:765. doi:10.1186/s12879-017-2816-8.
   PubMed Web of Science ®Google Scholar
• Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL. Pneumococcal carriage group. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11:841–55. doi:10.1586/erv.12.53.
   PubMed Web of Science ®Google Scholar
• The Coronavirus Scientific Advisory Board (Turkey). 2020 Apr 14. [accessed 2020 April 14]. https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf.
   Google Scholar
• Ceyhan M, Ozsurekci Y, Gurler N, Ozkan S, Sensoy G, Belet N, Hacimustafaoglu M, Celebi S, Keser M, Dinleyici EC, et al. Serotype distribution of streptococcus pneumoniae causing parapneumonic empyema in Turkey. Clin Vaccine Immunol. 2013;20:972–76. doi:10.1128/CVI.00765-12.
   PubMed Web of Science ®Google Scholar
• Turkey Ministery of Health. [ accessed 2019 Dec 20]. https://www.saglik.gov.tr/tr,11588/istatistik-yilliklari.html
   Google Scholar
• Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020;145:e20200702. doi:10.1542/peds.2020-0702.
   Web of Science ®Google Scholar
• [accessed 1951]. https://www.unhcr.org/1951-refugee-convention.html
   Google Scholar
• McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571–82.
   PubMed Web of Science ®Google Scholar
• Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013;309:275–82. doi:10.1001/jama.2012.194139.
   PubMed Web of Science ®Google Scholar
• Herzog H, Staub H, Richterich R. Gas-analytical studies in severe pneumonia; observation during the 1957 influenza epidemic. Lancet. 1959;1:593–97. doi:10.1016/S0140-6736(59)92351-7.
   PubMed Web of Science ®Google Scholar
• Wang XY, Kilgore PE, Lim KA, et al. Influenza and bacterial pathogen coinfections in the 20th century. Interdiscip Perspect Infect Dis. 2011;2011:146376. doi:10.1155/2011/146376.
   PubMedGoogle Scholar
• McCullers JA. Planning for an influenza pandemic: thinking beyond the virus. J Infect Dis. 2008;198:945–47. doi:10.1086/592165.
   PubMed Web of Science ®Google Scholar
• Gupta RK, George R, Nguyen-Van-Tam JS. Bacterial pneumonia and pandemic influenza planning. Emerg Infect Dis. 2008;14:1187–92. doi:10.3201/eid1408.070751.
   PubMed Web of Science ®Google Scholar
• LeVine AM, Koeningsknecht V, Stark JM. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods. 2001;94:173–86. doi:10.1016/S0166-0934(01)00287-7.
   PubMed Web of Science ®Google Scholar
• Loosli CG, Stinson SF, Ryan DP, Hertweck MS, Hardy JD, Serebrin R. The destruction of type 2 pneumocytes by airborne influenza PR8-A virus; its effect on surfactant and lecithin content of the pneumonic lesions of mice. Chest. 1975;67:7–14. doi:10.1378/chest.67.2_Supplement.7S.
   Web of Science ®Google Scholar
• Kash JC, Walters KA, Davis AS, Sandouk A, Schwartzman LM, Jagger BW, Chertow DS, Qi L, Kuestner RE, Ozinsky A, et al. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. MBio. 2011;2:e00172–11. doi:10.1128/mBio.00172-11.
   PubMed Web of Science ®Google Scholar
• Mossel EC, Wang J, Jeffers S, Edeen KE, Wang S, Cosgrove GP, Funk CJ, Manzer R, Miura TA, Pearson LD, et al. SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology. 2008;372:127–35. doi:10.1016/j.virol.2007.09.045.
   PubMed Web of Science ®Google Scholar
• Weinheimer VK, Becher A, Tonnies M, Holland G, Knepper J, Bauer TT, Schneider P, Neudecker J, Ruckert JC, Szymanski K, et al. Influenza A viruses target type II pneumocytes in the human lung. J Infect Dis. 2012(206):1685–94. doi:10.1093/infdis/jis455.
   Google Scholar
• Qian Z, Travanty EA, Oko L, Edeen K, Berglund A, Wang J, Ito Y, Holmes KV, Mason RJ. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol. 2013;48:742–48. doi:10.1165/rcmb.2012-0339OC.
   PubMed Web of Science ®Google Scholar
• Spelmink L, Sender V, Hentrich K, Kuri T, Plant L, Henriques-Normark B. Toll-like receptors 3/TRIF-dependent IL-12p70 secretion mediated by streptococcus pneumoniae RNA and its priming by influenza A virus coinfection in human dendritic cells. MBio. 2016;7:e00168–16. doi:10.1128/mBio.00168-16.
   PubMed Web of Science ®Google Scholar
• Tian X, Xu F, Lung WY, Meyerson C, Ghaffari AA, Cheng G, Deng JC. Poly I: C enhances susceptibility to secondary pulmonary infections by gram positive bacteria. PLoS One. 2012;7:e41879. doi:10.1371/journal.pone.0041879.
   PubMed Web of Science ®Google Scholar
• Li W, Moltedo B, Moran TM. Type I interferon induction during influenza virus infection increases susceptibility to secondary streptococcus pneumoniae infection by negative regulation of gamma delta T cells. J Virol. 2012;86:12304–12. doi:10.1128/JVI.01269-12.
   PubMed Web of Science ®Google Scholar
• Løvlie A, Vestrheim DF, Aaberge IS, Steens A. Changes in pneumococcal carriage prevalence and factors associated with carriage in Norwegian children, four years after introduction of PCV13. BMC Infect Dis. 2020;20:29. doi:10.1186/s12879-019-4754-0.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Greenberg D, Dagan R. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel. Human Vaccines &Immunotherapeutics. 2016;12(2):268–76. doi:10.1080/21645515.2015.1095414.
   PubMed Web of Science ®Google Scholar
• Moore MR, Hyde TB, Hennessy TW, Parks DJ, Reasonover AL, Harker-Jones M, Gove J, Bruden DL, Rudolph K, Parkinson A, et al. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible streptococcus pneumoniae in Alaska. J Infect Dis. 2004;190:2031–38.
   PubMed Web of Science ®Google Scholar
• Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, Goldblatt D, O’Brien KL, Whitney CG. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J. 2014;33(Suppl 2):S161–171. doi:10.1097/INF.0000000000000084.
   PubMed Web of Science ®Google Scholar
• Usuf E, Badji H, Bojang A, Jarju S, Ikumapayi UN, Antonio M, Mackenzie G, Bottomley C. Pneumococcal carriage in rural Gambia prior to the introduction of pneumococcal conjugate vaccine: a population-based survey. Trop Med Int Health. 2015;20:871–79. doi:10.1111/tmi.12505.
   PubMed Web of Science ®Google Scholar
• Mackenzie GA, Leach AJ, Carapetis JR, Fisher J, Morris PS. Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease. BMC Infect Dis. 2010;10:304. doi:10.1186/1471-2334-10-304.
   PubMed Web of Science ®Google Scholar
• Greenberg D, Givon-Lavi N, Broides A, Blancovich I, Peled N, Dagan R. The contribution of smoking and exposure to tobacco smoke to streptococcus pneumoniae and haemophilus influenzae carriage in children and their mothers. Clin Infect Dis. 2006;42:897–903. doi:10.1086/500935.
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MP, Harrison TG, Ladhani SN, Miller E. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England. Vaccine. 2014;32:4349–55. doi:10.1016/j.vaccine.2014.03.017.
   PubMed Web of Science ®Google Scholar
• Davis SM, Deloria-Knoll M, Kassa HT, O’Brien KL. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine. 2013;32:133–45. doi:10.1016/j.vaccine.2013.05.005.
   PubMed Web of Science ®Google Scholar
• Dagan R, Givon-Lavi N, Fraser D, Lipsitch M, Siber GR, Kohberger R. Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J Infect Dis. 2005;192:367–76. doi:10.1086/431679.
   PubMed Web of Science ®Google Scholar
• Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O’Brien KL, Satzke C, Simell B, Tanskanen A, K€ayhty H. Colonisation endpoints in Streptococcus pneumoniae vaccine trials. Vaccine. 2013;32:153–58. doi:10.1016/j.vaccine.2013.08.061.
   PubMed Web of Science ®Google Scholar
• Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, Casey DC, Charlson FJ, Chen AZ, Coates MM, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459–544.
   PubMed Web of Science ®Google Scholar
• [accessed 2020 July 15]. https://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%5B%5D=TUR&commit=OK
   Google Scholar
• Morpeth SC, Munywoki P, Hammitt LL, Bett A, Bottomley C, Onyango CO, Murdoch DR, Nokes DJ, Scott JAG. Impact of viral upper respiratory tract infection on the concentration of nasopharyngeal pneumococcal carriage among Kenyan children. Sci Rep. 2018;8:11030. doi:10.1038/s41598-018-29119-w.
   PubMed Web of Science ®Google Scholar